Carnitine alters binding of aflatoxin to DNA and proteins in rat hepatocytes and cell-free systems

被引:8
作者
Yatim, AM
Sachan, DS [1 ]
机构
[1] Univ Tennessee, Coll Human Ecol, Dept Nutr, Knoxville, TN 37996 USA
[2] Univ Tennessee, Agr Expt Stn, Knoxville, TN 37996 USA
关键词
aflatoxin B-1; choline; L-carnitine; gamma-aminobutyric acid; rats;
D O I
10.1093/jn/131.7.1903
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The objective of this study was to determine effects of L-carnitine on aflatoxin B-1 (AFB(1))-DNA adduct formation in isolated rat hepatocytes, its dose response, specificity and mode of action. All experiments were conducted in either freshly isolated rat hepatocytes or cell-free systems. There was negative linear correlation between the dosage of carnitine and formation of [H-3]AFB(1)-DNA adducts in the hepatocytes; however, the partitioning of AFB(1) into cellular compartments was not affected by carnitine. The attenuating effect of carnitine on AFB(1)-DNA adduct formation was also present in a cell-free system, but there was lack of specificity because acetylcarnitine and gamma -aminobutyric acid (GABA) were equally effective. Carnitine appears to interfere with bioactivation of AFB(1) and binding of AFB(1)-epoxide to DNA. On the contrary, carnitine enhanced the binding of AFB(1) and its epoxide to microsomal proteins, plasma proteins and bovine serum albumin. These results indicate that carnitine diverts AFB(1)-epoxide away from DNA by promoting binding to proteins. We conclude that modulation of AFB(1) binding to proteins and DNA by carnitine alters the carcinogenic and hepatotoxic potential of AFB(1) and poses concerns about the human AFB(1)-exposure data based on the AFB(1)-albumin adduct concentrations as a biomarker.
引用
收藏
页码:1903 / 1908
页数:6
相关论文
共 38 条
[1]  
ADAMSON RH, 1979, J NATL CANCER I, V57, P67
[2]  
ALLEMEH A, 1988, CANC LETT, V40, P49
[3]  
ANDERSON LO, 1979, PLASMA PROTEINS, P17
[4]   Effects of tamoxifen, melatonin, coenzyme Q10, and L-carnitine supplementation on bacterial growth in the presence of mycotoxins [J].
Atroshi, F ;
Rizzo, A ;
Westermarck, T ;
Ali-Vehmas, T .
PHARMACOLOGICAL RESEARCH, 1998, 38 (04) :289-295
[6]  
BHUIYAN AKMJ, 1994, BIOCHEM MOL BIOL INT, V34, P493
[7]  
CAMPBELL TC, 1978, CANCER RES, V38, P4569
[8]  
CERIOTTI G, 1952, J BIOL CHEM, V198, P297
[9]   ACETYLCARNITINE-MEDIATED INHIBITION OF ETHANOL OXIDATION IN HEPATOCYTES [J].
CHA, YS ;
SACHAN, DS .
ALCOHOL, 1995, 12 (03) :289-294
[10]  
CHANG LW, 1994, ANNU REV PHARMACOL, V34, P41